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Abstract
Background: Low protein diets (LPD) have long been prescribed to chronic kidney disease patients with the goals
of improving metabolic abnormalities and postpone the start of maintenance dialysis.
Methods: We reviewed the recent literature addressing low protein diets supplemented with ketoacids/essential
aminoacids prescribed during chronic kidney disease and their effects on metabolic, nutritional and renal
parameters since 2013.
Results: We show new information on how to improve adherence to these diets, on metabolic improvement and
delay of the dialysis needs, and preliminary data in chronic kidney disease associated pregnancy. In addition, data
on incremental dialysis have been reviewed, as well as potential strategies to reverse protein energy wasting in
patients undergoing maintenance dialysis.
Conclusion: These recent data help to better identify the use of low protein diets supplemented with
ketoacids/essential aminoacids during chronic kidney disease.
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Background
Maintenance dialysis is a burden for the global health sys-
tems globally and is growing at an unprecedented rate. A
recent analysis of the prevalence of end stage renal disease
led to the conclusion that the prevalence of maintenance
dialysis has grown more rapidly during the last two de-
cades than predicted [1]. Efforts to delay the progression to
end stage renal disease (ESRD) mainly rely on control of
blood pressure and diabetes. Unfortunately, in many coun-
tries nephrologists generally do not examine CKD patients
until dialysis is imminent and they have few options for
delaying the time to dialysis. However, increasing the time
until transition to dialysis therapy may improve patient’s
quality of life and can reduce the financial strain on the
healthcare system. Consequently, postponing dialysis initi-
ation should receive a high priority in majority of patients
with advanced CKD. In fact, there is evidence that many
patients will be able to postpone the transition to dialysis,
reportedly, more than 60 % of all CKD patients can experi-
ence a persistently low GFR (i.e., below 25 ml/min/
1.73 m2) during the two years prior to initiation of dialysis
[2, 3]. In short, there is opportunity to reduce the drivers
of chronic kidney disease, including poorly controlled
hypertension and decreased symptoms of uremia using a
low protein diet supplemented with ketoanalogues in
countries where these agents are available and including
dietary salt restriction [4, 5]. In jurisdictions without ap-
proved ketoacids such as the United States or Canada, es-
sential amino acids can be used instead. These strategies
were concisely reviewed in 2013 [6], therefore this review
will focus on evidence for efficacy that has become
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available since. In addition, it should be recalled that the
currently available ketoanalogues (KA) preparations are
marketed with other essential amino acids (EAA), which
will be referred as KA/EAA below in text.
How to improve adherence and select patients to
a KA/EAA-supplemented low protein diet
The general approach to treatment of patients with low or
supplemented very low protein diets often results in a tug
of war between the patient’s will to comply vs nutritional
temptations and deeply rooted food habits. Consequently,
doctors should consider that to attain good compliance it
is advisable to set goals of adherence – the conscious deci-
sion of the patient to stick with a therapy – as a thera-
peutic goal. To overcome this often frustrating situation,
Piccoli et al. [7] sought to identify factors that influence
patient adherence. They investigated implementation of a
simplified low-protein, KA/EAA supplemented diet as part
of the routine work-up of CKD patients. Patients with
CKD stages 4 to 5 or patients with CKD stage 3 and rapid
progression and/or a refractory nephrotic syndrome were
offered SLPD (0.6 g protein/kg/day). The endpoint was de-
fined as at least six months of follow-up on the diet and
the results were analysed by comparing demographic and
health parameters among patients following the diet for
less than one month vs. those who followed the restricted
diet for up to six months. The results indicated that suc-
cessful adherence was unpredictable a priori, as no medical
or social parameters were identified as indicative of con-
tinuous adherence to the SLPD [7]. Renal nutrition educa-
tion has also been reported to improve adherence to LPD
in a Brazilian randomized controlled trial [8].
Another recent study [9] from the same group addressed
the compliance issue in 185 patients given KA/EAA sup-
plemented LPD (0.6 g protein/kg/day supplemented with 1
tablet per 10 kg BW/day) vs 122 patients prescribed a LPD
with the same protein intake and commercially available
protein-free food. Adherence was assessed from food ques-
tionnaires, 24 h urine urea collection and tablet counts. Pa-
tients who chose SLPD were younger and had significantly
lower GFR values and higher levels of proteinuria. After six
months, the median protein intake was 0.7 g/kg BW/d in
both groups. Albumin and total protein levels were stable
at six and twelve months. Of note, even after GFR fell
below 15 ml/min, the diet was still followed by 59 % pa-
tients at six months and 32 % at twelve months. At one
year, all patients had reduced their albuminuria and degree
of acidemia. Interestingly the two low protein diets were
comparable in cost. Thus, compared to an “early start” dia-
lysis (i.e., when GFR is >10 ml/min), this dietary approach
of an KA/EAA supplemented 0.6 g protein/kg/day diet re-
sulted in substantial financial savings [10].
A landmark trial for the therapy with supplemented low
protein diet by Garneata et al. has been recently published
[11]. These investigators conducted a prospective, open,
parallel, randomized controlled study comparing vegetarian
VLPD (0.3 g/kg/day) supplemented with KA/EAA, 1 tab-
let/5 kg BW with LPD (0.6 g/kg/day) in non-diabetic pa-
tients with a stable eGFR below 30 ml/min/1.73 m2. The
study had a three-step enrolment procedure: patients were
asked if they would be willing to follow a low protein diet,
vegetarian if necessary; only those who were willing to do
so were included into a three month run-in period with a
low protein diet. 1,413 patients were assessed for eligibility
and 42 % of them declined to consider a vegetarian diet.
Dietary compliance was controlled monthly, and only pa-
tients who followed the diet were finally enrolled and
followed for up to 18 months. In the run-in phase, another
44 % dropped out, mainly for non-adherence to the LPD.
Thus only 14 % (207) of the patients initially eligible en-
tered the intervention period. The primary composite end-
point was initiation of dialysis or a reduction in the initial
eGFR by more than 50 %. The SVLPD resulted in a signifi-
cant delay of time to dialysis: while only 13 % in the SVLPD
group reached the primary endpoint, 42 % did in the non-
supplemented LPD group. Mean time to event was longer
in the SVLPD group with 57 (55–59) weeks vs 47 (43–50)
weeks in the control group (p < 0.001). The decline in eGFR
was slower in SVLPD group as compared to LPD with a
median difference between groups of 3.2 [2.6–3.8] mL/min.
At 15 months, only the SVLPD group experienced a signifi-
cant reduction of serum urea (120 [84–132] vs 167 [136–
273] mg/dL) and serum phosphorus (4.4 [4.1–4.8] vs 5.5
[4.3–6.9,] mg/dl) while serum calcium (4.5 [4.4–4.7] vs 3.9
(3.9–4.0), mg/dL) and serum bicarbonate increased signifi-
cantly (23.9 [21.5–25.1] vs 17.3 [15.3–18.7] mEq/L). The
adjusted “number needed to treat” (NNT) to avoid the pri-
mary composite endpoint was 4.0 (3.9–4.4). The adjusted
NNT to avoid dialysis initiation was 22.4 (21.5–25.1), but
decreased to 2.7 (2.6–3.1) when only patients with eGFR
<20 mL/min were retained in analysis. No significant
changes in nutritional status and no drug-related adverse
reactions were noted. Elderly (>65 years) and young active
patients (<45 years) seemed to more easily accept the diet-
ary intervention. Strong family/social support and, being
already vegan or vegetarian were also identified as support-
ive characteristics [11]. Thus, adherence to a SVLPD can be
achieved only if a good selection strategy is made and test
periods are performed. Overall however, only 30 % of the
pre-selected patients correctly achieved the very low pro-
tein intake reduction.
New features of low protein diets in chronic kidney
disease and dialysis
Pregnancy
It has long been feared that provision of a LPD to preg-
nant patients with CKD could interfere with growth of
the foetus. Piccoli et al. [12]. assessed the effect of a
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vegan-based LPD supplemented with KA/EAA on fetal
growth in pregnant women with CKD. In an open, inter-
ventional study of pregnant patients with stage 3–5
CKD or with proteinuria (>1 g/d in the first trimester or
the presence of nephrotic-range proteinuria at any time),
positive outcomes were observed during an evaluation
from 2000 to 2012. Specifically, the patients treated with
a LPD (0.6–0.8 g/kg per day) supplemented with KA/
EAA plus 1 to 3 protein-unrestricted meals/week main-
tained a good nutritional status. In comparison to preg-
nant CKD women who did not receive LPD for various
reasons (late referral, stable disease, previous nutritional
problems), the women treated with protein-restricted-
KA/EAA diets had fewer new-borns that were “small for
gestational age” (i.e., 3 of 21 pregnancies) compared to
those fed ad libitum (i.e., 7 of 16; p = 0.05) [12]. The
mothers and children were followed for periods of six
months to ten years and those treated with LPD-KA/EAA
regimen had lower rates of hospitalization even though
the prevalence of children below the third growth percent-
ile were similar to events in the mothers fed ad libitum.
These clinical outcomes certainly deserve to be tested in
larger multicentre studies.
Maturating arteriovenous fistulas
Can low protein diets help expanding time until initi-
ation of dialysis? The best timing of dialysis initiation
has long been a matter of debate and the IDEAL study
[13] has proven that an early dialysis start may be haz-
ardous. In addition, too often nephrologists do not be-
come involved in the care of CKD patients until dialysis
is imminent. Besides obvious advantages of an earlier re-
ferral of CKD patients to the nephrologist, late referrals
may even interfere with the patients being introduced
properly to dialysis (e.g., inadequate time to create a func-
tional arteriovenous access or the option to be trained for
peritoneal dialysis). Duenhas et al. [14] prospectively en-
rolled 21 patients who were scheduled to start haemodi-
alysis based on serum urea reached ≥ 175 mg/dl and the
creatinine clearance was ≤ 12 ml/min. These patients were
advised to consume a “very low protein diet” (VLPD;
0.3 g/kg/day) consisting mainly of vegetable proteins and
KA/EAA for 30 days to allow maturation of arteriovenous
access and/or training for peritoneal dialysis. Ten of these
patients (47.3 %) developed a matured permanent dialysis
access within a mean follow up of 83.3 ± 58.2 days. Serum
concentration of urea dropped significantly from a mean
of 175.3 ± 48.3 mg/dl to 109.0 ± 25.8 mg/dl (p < 0.001).
Serum calcium and phosphorus were improved while
body mass index, muscle mass and other biochemical pa-
rameters including serum albumin were unchanged. The
authors conclude that a very low protein diet supple-
mented with KA/EAA can maintain stable or even im-
proved metabolic status in patients with very low renal
function with no deterioration in protein-energy status
until initiation of dialysis via a permanent dialysis access
fistula [14]. These findings are of major clinical and public
health importance because recent guidelines [15] call for
an “intent-to-defer” as more efficacious compared to an
“intent-to-start-early” approach in planning for the initi-
ation of chronic dialysis in adults with an estimated GFR
(eGFR) of less than 15 ml/min/1.73 m2. Authors of this
consensus paper emphasize that better health-related
quality of life and fewer burdens associated with earlier
initiation of dialysis without clinical indications should be
the goal, especially because some complications of urae-
mia may be avoided. In addition, this may help containing
dialysis expenses as well [16].
Incremental dialysis
Incremental dialysis should be discussed when searching
for alternate dialysis initiation models. Indeed, the IDEAL
trial [13] clearly showed that an early start of hemodialysis
was of no benefit to patients, and as a consequence, an
interest in incremental hemodialysis [17, 18] has recently
arisen. This consists of one or two weekly hemodialysis
sessions, based on the patient’s residual renal function and
degree of metabolic abnormalities. As renal function de-
creases and/or metabolic disorders related to kidney fail-
ure increase, the patients dialysis dose increases until they
begin a full thrice-weekly dialysis schedule. In a prospect-
ive non-randomized study of 85 Chinese MHD patients,
after one year, those who were receiving twice dialysis ses-
sions weekly did not show clinical or metabolic differences
with patients under the regular thrice weekly regimen, ex-
cept for residual diuresis which was better conserved in
the twice-weekly group of patients [19]. In this setting, a
prescription of a KA/EAA-supplemented very low protein
diet may be considered to be an effective diet for main-
taining a twice-weekly hemodialysis regimen for some
more months and delay the loss of residual renal function
[19], as it has also been reported in patients receiving peri-
toneal dialysis [20].
Nutritional supplement during maintenance dialysis
It has been suggested that KA/EAA supplements might be
considered for maintenance dialysis patients who present
with protein energy wasting [21]. It has been showed that
nutritional support, either enteral or intravenous, is able to
reverse protein-energy wasting in wasted MHD patients
[22]. This hypothesis, already suggested by Hiroshige et al.
[23] who used branched-chain amino acids, has not yet
been addressed by adequate clinical trials using KA/EAA
and therefore should be a subject for future research. Pre-
liminary data from a recent Chinese randomized trial in
100 chronic peritoneal dialysis patients, those patients who
received KA/EAA supplements displayed reduced inflam-
matory status and a decreased serum leptin/adiponectin
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ratio as compared with the control group [24]. In addition,
reducing protein intake with the addition of KA/EAA sup-
plements, under strict dietary and nutritional assessments
may help controlling serum phosphate in countries where
limited phosphate binders are available [25, 26].
Conclusion
Recent reports provide additional information that can be
offered to advanced CKD patients, in order to help motiv-
ate them to adhere to these low and very low protein diets.
These studies also provide additional evidence supporting
the safety of these diets. Adherence to a protein-restricted
diet can be improved by selecting patients and offering
them tailored dietary choices. Taken together, these new
research data confirm an overall picture that a low protein
diet providing 0.3–0.6 g/kg BW/d with added KA/EAA
supplements may improve proteinuria [27] and delays
time until dialysis has to be started [28]. The latter most
likely occurs because uremic toxicity is reduced.
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